Signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92

American Journal of Reproductive Immunology

Volumn 66, Issue 4, 2011, Pages 329-335

  Braunschweig, Anne ^a   Poehlmann, Tobias G ^a   Busch, Susann ^a   Schleussner, Ekkehard ^a   Markert, Udo R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cytotoxicity; Decidua; Decidual NK cells; Interleukin 10; Natural killer cells; Placentation; SOCS3; STAT3

Indexed keywords

GAMMA INTERFERON; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; PERFORIN; SMALL INTERFERING RNA; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN; CELL STRAIN K 562; CELL STRAIN NK 92; CONTROLLED STUDY; CYTOKINE PRODUCTION; DECIDUA; HUMAN; HUMAN CELL; IMMUNOREGULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

BLOTTING, WESTERN; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; DECIDUA; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMANS; INTERLEUKIN-10; K562 CELLS; KILLER CELLS, NATURAL; PHOSPHORYLATION; PREGNANCY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TYROSINE;

EID: 80052573234     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.00989.x     Document Type: Article

References (28)

1. Rabot M, Tabiasco J, Polgar B, Aguerre-Girr M, Berrebi A, Bensussan A, Strbo N, Rukavina D, Le Bouteiller P: HLA class I/NK cell receptor interaction in early human decidua basalis: possible functional consequences. Chem Immunol Allergy 2005; 89:72-83.
2. El Costa H, Casemayou A, Aguerre-Girr M, Rabot M, Berrebi A, Parant O, Clouet-Delannoy M, Lombardelli L, Jabrane-Ferrat N, Rukavina D, Bensussan A, Piccinni MP, Le Bouteiller P, Tabiasco J: Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J Immunol 2008; 181:3009-3017.
3. Bogovic Crncic T, Laskarin G, Juretic K, Strbo N, Dupor J, Srsen S, Randic L, Le Bouteiller P, Tabiasco J, Rukavina D: Perforin and Fas/FasL cytolytic pathways at the maternal-fetal interface. Am J Reprod Immunol 2005; 54:241-248.
4. Poehlmann TG, Schaumann A, Busch S, Fitzgerald JS, Aguerre-Girr M, Le Bouteiller P, Schleussner E, Markert UR: Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1. Am J Reprod Immunol 2006; 6:275-285.
5. Rukavina D, Podack ER: Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant? Immunol Today 2000; 21:160-163.
6. Rakesh K, Agrawal DK: Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol 2005; 70:649-657.
7. Poehlmann TG, Busch S, Mussil B, Winzer H, Weinert J, Mebes I, Schaumann A, Fitzgerald JS, Markert UR: The possible role of the Jak/STAT pathway in lymphocytes at the fetomaternal interface. Chem Immunol Allergy 2005; 89:26-35.
8. Poehlmann TG, Fitzgerald JS, Meissner A, Wengenmayer T, Schleussner E, Friedrich K, Markert UR: Trophoblast invasion: tuning through LIF, signalling via Stat3. Placenta 2005; 26(Suppl A):S37-S41.
9. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA: Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 1999; 18:375-385.
10. Chiossone L, Vitale C, Cottalasso F, Moretti S, Azzarone B, Moretta L, Mingari MC: Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 2007; 109:3767-3775.
11. Manaster I, Mandelboim O: The unique properties of human NK cells in the uterine mucosa. Placenta 2008; 29(Suppl A):S60-S66.
12. Imada K, Leonard WJ: The Jak-STAT pathway. Mol Immunol 2000; 37:1-11.
13. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S: Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10:39-49.
14. Frank DA, Robertson MJ, Bonni A, Ritz J, Greenberg ME: Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc Natl Acad Sci USA 1995; 92:7779-7783.
15. Trundley AE, Hiby SE, Chang C, Sharkey AM, Santourlidis S, Uhrberg M, Trowsdale J, Moffett A: Molecular characterization of KIR3DL3. Immunogenetics 2006; 57:904-916.
16. Yu Y, Wang Y, Feng M: Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse. Hum Immunol 2008; 69:16-23.
17. Kalina U, Kauschat D, Koyama N, Nuernberger H, Ballas K, Koschmieder S, Bug G, Hofmann WK, Hoelzer D, Ottmann OG: IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J Immunol 2000; 165:1307-1313.
18. Yao AY, Tang HY, Wang Y, Feng MF, Zhou RL: Inhibition of the activating signals in NK92 cells by recombinant GST-sHLA-G1a chain. Cell Res 2004; 14:155-160.
19. Wendt K, Wilk E, Buyny S, Schmidt RE, Jacobs R: Interleukin-21 differentially affects human natural killer cell subsets. Immunology 2007; 122:486-495.
20. Erlebacher A, Zhang D, Parlow AF, Glimcher LH: Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system. J Clin Invest 2004; 114:39-48.
21. Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H: Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. Mol Endocrinol 2007; 21:2218-2232.
22. Mavoungou E: Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy. Clin Med Res 2006; 4:33-41.
23. Ziegler-Heitbrock L, Lotzerich M, Schaefer A, Werner T, Frankenberger M, Benkhart E: IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J Immunol 2003; 171:285-290.
24. Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R: Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 2004; 4:679-691.
25. Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, Takaki H, Himeno K, Takaesu G, Kobayashi T, Yoshimura A: Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J Exp Med 2006; 203:1021-1031.
26. Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, Hilton DJ, Alexander WS: Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci USA 2001; 98:9324-9329.
27. Robb L, Boyle K, Rakar S, Hartley L, Lochland J, Roberts AW, Alexander WS, Metcalf D: Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease. Proc Natl Acad Sci USA 2005; 102:16333-16338.
28. Fitzgerald JS, Toth B, Jeschke U, Schleussner E, Markert UR: Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy. J Reprod Immunol 2009; 83:117-123.